Author Archives: Pharmco

Pharmco International to Launch Contract Manufacturing

August 29, 2009: Pharmco International announced today the establishment of a new contract manufacturing and private labeling line of business.

The new venture is planned to take shape in the beginning of 2010 and is set up to provide Pharmco’s customers, both domestic and international, a way to privately brand new products for each respective line. This move allows Pharmco to take advantage of its existing supply chain, suppliers and logistics system to provide each customer more value.

“We are very excited to start work with all of our upstream suppliers so that we may better support our customer set and fully utilize our current operations, knowledge and experience in this market.” says, TR Kuo, President of Pharmco.

Pharmco Appoints China Distributor for Multi-Vitamins

June 19, 2007: Pharmco International, Inc. announced today the planned launch of their Century line of vitamin and mineral products for market and sale in the People’s Republic of China.

The products, which are currently being submitted to the China State Food Supplement and Drug Administration for registration, are planned to launch in China in the back half of 2008. The products are to include the Century Multi-Vitamin Tablets and the Century Senior Multi-Vitamin Tablets.

“Asia, with mainland China in particular, is undergoing a major economic shift with consumers’ annual incomes increasing and information more readily available. With more disposable income, they are able to add other items to their monthly expenditures. Items that would otherwise be viewed as unnecessary. With more knowledge, they are making better buying decisions and determining that preventative medicine is quickly becoming a necessity. We at Pharmco are very happy to be able to bring new products to China for the betterment of the population.”

Pharmco has announced it is partnering with C&O Pharmaceutical Technology (Holdings) Limited, who went public on the Mainboard of the Singapore Stock Exchange in 1995. C&O has been in the healthcare market within mainland China for over 10 years and was a previous indirect vendor to Pharmco on previous products.

“The Century Series compliments our existing product portfolio well. We are pleased that Pharmco shares our optimism for the market and recognizes our years of experience and strong track record in distributing imported pharmaceutical products in China. We look forward to a mutually beneficial working relationship by growing together in China”, said Mr. Gao Bin, Executive Chairman of C&O.

“We, at Pharmco, are very excited to partner with C&O on our Century line of products. It has been our experience that partnering with knowledgeable, experienced, trustworthy companies is the key to success. That has been our goal for all of our markets and what has made our presence a success in mainland China. We will continue bring new, improved and cutting edge products to the population in China under the Century brand with the help of C&O in the very near term.”

Osteoform Junior to Launch

January 1, 2007: Dallas, Texas: Pharmco International, Incorporated announced today that it is in the final stages of development for an Osteoform line extention. Osteoform Junior, an oral dissolving bone supplement tabelt desigined specifically for children, is planned to launch in the United States in mid-2007.

“We wanted to come up with a product that is both appealing for children as well as easy to take. Taking a long look at the current market we realized that there is a real need for a product that is easy to take and appeals to children.” Pharmco also added “Current chewables in the market are compressed pretty hard which makes chewing it more difficult for children and requires a fairly developed set of teeth to do so. That coupled with the chalky aftertaste makes taking children’s supplements unappealing. Our new Osteoform Jr. dissolves orally and does not leave a chalky aftertastes and appeals more to children.”

Pharmco also plans to launch Osteoform Junior in other countries starting at the end of 2007 or beginning of 2008.

For more information, please visit Pharmco International, Incorporated atwww.pharmcousa.com.

Or email us at sales@pharmcousa.com

Pharmco to Launch Protein Line in Shanghai

December 1, 2004: Beijing, China: Pharmco International Incorporated announced today that it is planning its launch of the Maxorb Protein Meal Replacement line of products in the Shanghai market during the 1st quarter of 2005.

According to company officials, Pharmco and its regional distribution partner, Shanghai Polar Bioengineering Company, Limited, are in final discussions with Lian Hua Supermarkets. Lian Hua Supermarkets is one of the largest supermarket chains in southern China with more than 300 stores in Shanghai alone. The initial launch is planned for 100 of these stores. The products are scheduled to hit the shelves in early January 2005.

This move by Pharmco is targeted to capture the market’s spend for the Chinese New Year Holiday, a major gift giving season in China. “Shanghai is home to over 16 million people and is one of our must win districts within Mainland China. This combined with the Chinese New Year Season is a perfect opportunity for our company to enter this diverse market,” a company spokesperson states.

For more information, please visit Pharmco International, Incorporated atwww.pharmcousa.com.

Or email us at sales@pharmcousa.com

Maxorb to Sponsor Chinese University National Team

October 18, 2004: Beijing, China: Pharmco International Incorporated announced today that their Maxorb Protein Meal Replacement has been chosen as the Official Nutritional Product of the Chinese University National Team representing China in the 2005 World University Games to be held in Austria and Turkey.

The World University Games (WUG) are held every two years under the auspices of the International University Sports Federation (FISU) and are separated into two competitions held at different venues at different times. The 2005 World University Winter Games (WUWG) are to be held in Innsbruck, Austria from January 12-21, 2005. The WUWG 2005 are comprised of competitions in ten (10) winter sports disciplines. The snow sport disciplines to be contested are: Alpine Skiing, Nordic Skiing, Biathlon, Short Track Speed Skating, Snowboarding, Figure Skating, and Ice Hockey.

The 2005 World University Summer Games (WUSG), previously held in Beijing, China in 2001, are to be held in Izmir, Turkey from August 11-21. The WUSG comprises competition in 10 compulsory sports and up to 3 optional sports determined by the host, Turkey. The compulsory sports to be contested are Athletics, Basketball, Fencing, Football, Gymnastics – artistic and rhythmic, Swimming, Diving, Water Polo, Tennis, Volleyball. The optional sports to be contested are Sailing, Taekwondo and Wrestling.

As the Official Nutritional Product of the Chinese University National Team representing China in both the 2005 World University Winter Games and 2005 World University Summer games, Pharmco’s Maxorb Protein Meal Replacement will be available to all athletes competing for the purposes of preparation, conditioning and competition.

For more information, please visit Pharmco International, Incorporated atwww.pharmcousa.com.

Or email us at sales@pharmcousa.com

Maxorb Chosen as Official Product of 2005 CUBA Season

October 11, 2004: Pharmco International, Inc. has announced today that their Maxorb Protein Meal Replacement has just been chosen as the Official Nutritional Product of the Chinese University Basketball Association, CUBA, for the 2004-2005 College Basketball season.

The 2004-2005 season marks the first time the major Chinese Universities have come together and competed in a nationwide competition for a national championship title. Up until this year, season competition has been regional as opposed to nationwide. The season tip-off is to begin on October 30, 2004 with competition lasting until the end of June 2005. 16 universities in 13 different cities and provinces are scheduled to compete during this 128 game season for the national championship.

“We at Pharmco are very exited and pleased to be a part of such a growing sport in China. We are even happier that we will be able to play a part in the youth development in China and to be able to help the athletes in their preparation and competition throughout this years season…” as stated by the Director of Business Development, Mr. Alex Kuo.

As the Official Protein Product of the 2004-2005 CUBA season, Pharmco’s Maxorb Protein Meal Replacement will be available to all players during the season and will be used for preparation and conditioning throughout the season. Pharmco will also be distributing product samples during the games to attendees, estimated at over 250,000 people over the span of the season. Maxorb billboard banners will be set up at each game with Maxorb logos on each ticket stub, season schedule, in game programs as well as any television advertisement for the inaugural season.

For more information, please visit Pharmco International, Incorporated atwww.pharmcousa.com.

Or email us at sales@pharmcousa.com

Pharmco Plans New Protein Launch for China

March 12, 2004: Pharmco International, Inc. announced today that they will be launching a protein line of products for market in Mainland China planned for launch during the 4th quarter of 2004. This venture is to further develop the company’s initiative into the “phood” industry.

As a company spokesperson states, “with the Chinese population’s diet lacking in so many nutritional areas, we want to concentrate on developing products that are more preventative in nature as opposed to pharmaceutical products that are more reactive and are taken in response to a physical need…we believe our new protein line will fit that mold and provide more nutrients to the population’s diet, therefore, helping to prevent diseases caused by nutritional deficiencies.”

Pharmco plans to launch the protein line of products under its Maxorb brand name. Company representatives state that the initial launch will be a protein meal replacement product for market in all of the major cities within Mainland China. The meal replacement product will be available in three formulations: Adult, Children’s and Sport. All of these formulations are to be available in three flavors: Chocolate, Almond and Strawberry.

Company released timeline has the three formulations staggered through the 4th quarter of 2004 to the 1st quarter of 2005.

For more information, please visit Pharmco International, Incorporated atwww.pharmcousa.com.

Or email us at sales@pharmcousa.com

Osteoform Obtains Approval by Chinese Ministry of Public Health

January 24, 1995: Pharmco International, Incorporated announced today that they have obtained their first prescription drug registration in China. “Osteoform” one of their unique chelated products to help prevent osteoporosis and increase bone density, was approved by the Chinese Ministry of Public Health as a prescription drug within the People’s Republic of China. “Osteoform” contains nine organic chelated minerals that release slowly in the intestines to increase the absorption rate and effectiveness. Other calcium products using general minerals can form insoluble hydroxides, which negatively influence the absorption of these minerals. A side effect of these calcium products include upset stomach, which is in large part due the insoluble hydroxides that form. Osteoform prevents upset stomach from occurring by changing the absorption process. “Osteoform” also vitamin D3 to aid in preventing bone deterioration.

Pharmco will begin distribution of “Osteoform” in late February in the People’s Republic of China. “Osteoform” will launch in the major provinces first with plans to be widely available throughout China by the end of the year. “Osteoform” has been chosen by the Chinese government as the ONLY calcium product to be used for clinical trials in osteoporosis research performed by the Ministry of Public Health, People’s Republic of China and the Chinese Scientific Institute.

For more information, please visit Pharmco International, Incorporated atwww.pharmcousa.com.

Or email us at sales@pharmcousa.com

Pharmco Ventures into Services Industry

March 16, 2002: Pharmco International, Inc announced today that they will be launching a services group to provide pharmaceutical consulting and distribution services within the People’s Republic of China.

Pharmco spokesperson stated, “we want to introduce and bring value added pharmaceutical and OTC consumer products that are available in other countries to the Asian population…Chinese pharmaceutical industry is sometimes one to two generations behind from a technology perspective. The Chinese and Asian population does not, in many cases, have access to the latest ethical drugs and consumer products that other countries do. We want to be able to bring “western medicine” to the Asian market to better the lives of the people.”

Pharmco’s services group will be providing consulting and distribution services to pharmaceutical companies that want to expand into the Asian marketplace. These services will be available in China in July of 2002 and will spread throughout Asia starting in 2004.

The consulting services will include product registration/government approval consultation, market consultation and distribution consultation. Product registration/government approval consultation involves the steps and procedures in getting a product approved for sale by the Chinese Ministry of Public Health either as an over the counter drug or a prescription drug. Market consultation is a study of the target market to determine who to launch to product to, where to launch the product and how to inform the market of the product. Distribution consultation is centered around how to get the product to market via the distribution network in China.

The distribution services involve Pharmco assuming responsibility for the product going to market. They will register the product, determine the target market, get the product in distribution and advertise for the product.

For more information, please visit Pharmco International, Incorporated atwww.pharmcousa.com.

Or email us at sales@pharmcousa.com